NEOS Investment Management LLC Has $13.77 Million Stock Holdings in CME Group Inc. $CME

NEOS Investment Management LLC grew its position in CME Group Inc. (NASDAQ:CME) by 32.5% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 50,977 shares of the financial services provider’s stock after purchasing an additional 12,503 shares during the period. NEOS Investment Management LLC’s holdings in CME Group were worth $13,773,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Norges Bank bought a new stake in CME Group during the 2nd quarter worth about $1,571,447,000. Mawer Investment Management Ltd. grew its position in shares of CME Group by 107.2% during the 3rd quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider’s stock worth $406,029,000 after buying an additional 777,571 shares during the period. Viking Global Investors LP bought a new stake in shares of CME Group during the second quarter worth approximately $164,648,000. Vanguard Group Inc. raised its stake in shares of CME Group by 1.5% during the second quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock worth $9,695,313,000 after buying an additional 532,549 shares during the last quarter. Finally, Magellan Asset Management Ltd lifted its holdings in CME Group by 131,625.5% in the second quarter. Magellan Asset Management Ltd now owns 486,067 shares of the financial services provider’s stock valued at $133,970,000 after buying an additional 485,698 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

CME has been the subject of a number of analyst reports. UBS Group reaffirmed a “neutral” rating and set a $310.00 target price on shares of CME Group in a report on Friday, February 6th. Deutsche Bank Aktiengesellschaft raised their price target on CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Piper Sandler upped their price objective on CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Royal Bank Of Canada raised their target price on CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a report on Thursday, February 5th. Finally, JPMorgan Chase & Co. boosted their target price on CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a research report on Thursday, February 5th. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $299.53.

Insider Buying and Selling at CME Group

In other CME Group news, Director Dennis Suskind sold 748 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $300.00, for a total value of $224,400.00. Following the sale, the director owned 2,699 shares in the company, valued at approximately $809,700. The trade was a 21.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This represents a 27.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.30% of the company’s stock.

CME Group Price Performance

NASDAQ CME opened at $303.23 on Wednesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. The stock has a market cap of $109.34 billion, a price-to-earnings ratio of 27.17, a PEG ratio of 3.29 and a beta of 0.27. The business has a 50 day simple moving average of $281.14 and a 200 day simple moving average of $274.30. CME Group Inc. has a 52-week low of $244.43 and a 52-week high of $309.35.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the prior year, the company earned $2.52 earnings per share. The business’s quarterly revenue was up 8.1% compared to the same quarter last year. Analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date is Tuesday, March 10th. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. CME Group’s dividend payout ratio is currently 46.59%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.